$375 Million is the total value of Samsara BioCapital, LLC's 57 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $90,281,000 | +20.2% | 5,161,888 | +12.4% | 24.07% | +27.2% |
| NKTX | Buy | NKARTA INC | $35,334,000 | +52.6% | 2,868,035 | +41.0% | 9.42% | +61.6% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $25,248,000 | +476.7% | 4,598,828 | +1254.1% | 6.73% | +510.7% |
| GRPH | Buy | GRAPHITE BIO INC | $23,263,000 | -43.5% | 8,459,314 | +4.8% | 6.20% | -40.2% |
| Buy | ARCELLX INC | $19,234,000 | +37.2% | 1,063,835 | +6.4% | 5.13% | +45.3% | |
| LYRA | New | LYRA THERAPEUTICS INC | $10,041,000 | – | 1,777,251 | +100.0% | 2.68% | – |
| New | HILLEVAX INC | $8,335,000 | – | 762,577 | +100.0% | 2.22% | – | |
| New | PEPGEN INC | $6,465,000 | – | 651,050 | +100.0% | 1.72% | – | |
| Buy | DICE THERAPEUTICS INC | $3,934,000 | -10.0% | 253,466 | +10.9% | 1.05% | -4.6% | |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $2,130,000 | -7.9% | 304,715 | +8.9% | 0.57% | -2.4% |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $37,000 | – | 133,333 | +100.0% | 0.01% | – |
| New | SURROZEN INC*w exp 08/01/203 | $19,000 | – | 99,999 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.